Loading organizations...
§ Private Profile · New Albany, IN, USA
RxLightning is a technology company.
RxLightning develops the MedAccess Ecosystem, a unified digital platform streamlining specialty prescription enrollment. It digitizes forms, automates benefit verification, and manages prior authorizations and patient assistance programs, simplifying medication access. The platform utilizes secure APIs for EHR integration and maintains adherence to FHIR protocols, HITRUST, and HIPAA compliance for secure and efficient processing.
Founded by CEO Julia Regan and CTO Brad Allen, RxLightning emerged from the critical insight that specialty medication onboarding was an archaic, paper-intensive, and unreliable process. They recognized that manual systems caused significant delays for patients requiring critical therapies. This understanding propelled them to build a centralized digital solution to eliminate inefficiencies and expedite access to vital treatments.
RxLightning serves providers, manufacturers, specialty pharmacies, and patients with its consistent digital onboarding experience. Its mission is to accelerate patient access to essential therapies by transforming the enrollment process into a seamless, barrier-free journey. The company envisions a future where complex medication onboarding never impedes critical treatment.
RxLightning has raised $21.0M across 2 funding rounds.
RxLightning has raised $21.0M in total across 2 funding rounds.
RxLightning has raised $21.0M across 2 funding rounds. Most recently, it raised $18.0M Series A in June 2023.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Jun 1, 2023 | $18M Series A | Josh Flum | HealthX Ventures, Vensana Capital, Hearst Ventures, Carrie (Hurwitz) Williams, Novartis, Rana Lonnen, Onco360 | Announced |
| Jun 16, 2021 | $3M Seed | Taha Jangda | — | Announced |
RxLightning has raised $21.0M in total across 2 funding rounds.
RxLightning's investors include Josh Flum, HealthX Ventures, Vensana Capital, Hearst Ventures, Carrie (Hurwitz) Williams, Novartis, Rana Lonnen, Onco360, Taha Jangda.
RxLightning is a healthcare technology company that builds an award-winning digital platform to simplify, automate, and streamline the complex onboarding process for specialty medications.[1][2][5] It serves providers, patients, pharmaceutical manufacturers, specialty pharmacies, and health systems by digitizing enrollment forms, enabling real-time benefit checks, prior authorizations, consent collection, and access to patient assistance programs—reducing enrollment time from weeks to minutes and accelerating speed-to-therapy.[1][2][4][5] The platform solves the historically manual, paper/fax/phone-based specialty medication access challenges, including fragmented systems and administrative burdens, through its MedAccess Ecosystem that provides visibility across stakeholders.[1][3] With strong growth momentum, RxLightning has secured $20.5 million in funding from investors like LRVHealth, McKesson Ventures, and Novartis Ventures, won multiple awards (e.g., PM360 Most Innovative Company, four Mira Awards), and was acquired by CoverMyMeds to enhance patient support program enrollment.[1][3][5][6]
RxLightning was founded in January 2020 by Julia Regan (CEO) and Brad Allen (CTO) to address the inefficient specialty medication enrollment process, which often took days or weeks due to brand-specific forms, portals, faxes, and phone calls.[2][3] Julia Regan brings over 15 years of healthcare innovation experience, including real-time benefit checks and medication onboarding tools, while Brad Allen leads scalable, cloud-based technology development.[3] The idea emerged from recognizing the fastest-growing pharmaceutical segment's unmet need for a comprehensive, free-to-providers solution that serves any specialty medication (brand or generic) at any pharmacy.[2] Early traction included partnerships with a Top 10 specialty pharmacy and IllumiCare for EMR integration, plus rapid award wins like Startup of the Year in 2022.[2][3][5]
RxLightning rides the wave of digital transformation in healthcare, targeting the booming specialty medication market—the fastest-growing pharmaceutical segment—where manual processes delay care and increase costs.[2][4] Timing is ideal amid rising demand for high-cost therapies in areas like oncology and rare diseases, amplified by post-pandemic emphasis on efficiency, telehealth, and patient-centric tech.[1][3] Market forces favoring it include payer pressures for faster approvals, pharmacy revenue optimization via foundation matching, and regulatory pushes for transparency, all addressed by its automation.[4] It influences the ecosystem by partnering across stakeholders, setting standards for unified enrollment (now boosted via CoverMyMeds acquisition), and enabling health systems to capture scripts, improve adherence, and prioritize affordability—paving the way for more connected care journeys.[4][6]
RxLightning's acquisition by CoverMyMeds positions it to scale nationally, integrating deeper into prior authorization and PSP workflows for even faster therapy access.[6] Trends like AI-driven personalization, expanded foundation networks, and EMR ubiquity will amplify its platform, potentially dominating specialty onboarding as specialty drugs grow to 50%+ of pharma spend. Its influence may evolve from disruptor to infrastructure layer, powering compassionate, frictionless care and redefining medication access for millions—fulfilling its "For the One" mission at lightning speed.[3][6]